These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2697404)

  • 1. Prognostic factors and treatment of myelodysplastic syndromes.
    Mijović A; Bosković D; Elezović I; Tomin D; Gotić M; Janosević S; Rolović Z
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():61. PubMed ID: 2697404
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose Ara-C in the treatment of myelodysplastic syndromes.
    Bogdanić V; Labar B; Mrsić M; Nemet D; Serventi-Seiwerth R
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():26-7. PubMed ID: 2697395
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myelodysplastic syndrome and myelogenous leukemia. Treatment with low-dose cytarabine].
    Waage A; Hammerstrøm J; Lødemel B; Hoff JE; Langtind J
    Tidsskr Nor Laegeforen; 1986 Feb; 106(6):496-7. PubMed ID: 3457484
    [No Abstract]   [Full Text] [Related]  

  • 4. Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukemias and myelodysplastic syndromes.
    Tambone Reyes M; Bonaccorso R; Gebbia V; Tinnirello D; Di Salvo V; Ciulla A; Di Marco P; Mansueto S; Citarrella P
    J Chemother; 1989 Jul; 1(4 Suppl):1276-8. PubMed ID: 16312864
    [No Abstract]   [Full Text] [Related]  

  • 5. [A therapeutic trial with low-dose Ara-C in acute nonlymphocytic leukemia and myelodysplastic syndromes: a study of 15 cases].
    Maruta A; Miyashita H; Kodama F; Harano H; Kanamori H; Takahashi K; Noguchi T; Matsuzaki M; Ogawa K; Motomura S
    Rinsho Ketsueki; 1988 Jan; 29(1):8-13. PubMed ID: 3385938
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ventricular fibrillation in a patient with myelodysplastic syndrome treated with small doses of cytarabine].
    Drzewoski J; Krykowski E; Robak T; Jerzmanowski P; Kusowska J; Koźbiał H
    Kardiol Pol; 1989; 32(4):225-8. PubMed ID: 2622113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myelodysplastic syndromes].
    Guisasola Zulueta MC; Gilsanz Fernández C; Tintó del Val JA; García de la Fuente A
    Rev Clin Esp; 1986 Sep; 179(4):190-5. PubMed ID: 3764008
    [No Abstract]   [Full Text] [Related]  

  • 8. Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes.
    Giles FJ; Kantarjian HM; Cortes JE; Faderl S; Verstovsek S; Thomas D; Garcia-Manero G; Wierda W; Ferrajoli A; Kornblau S; Mattiuzzi GN; Tsimberidou AM; Albitar M; O'Brien SM; Estey E
    Leuk Res; 2005 Jun; 29(6):649-52. PubMed ID: 15863204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the therapy for myelodysplastic syndrome.
    Kasner MT; Luger SM
    Am J Hematol; 2009 Mar; 84(3):177-86. PubMed ID: 19195035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of low dose Ara-C in acute nonlymphocytic leukemia and myelodysplastic syndromes--analysis of factors influencing the duration of responses, survival and clinical effects].
    Sawada H; Abe T; Akasaka K; Ishikura H; Izumi Y; Inamoto Y; Usui T; Okazaki T; Okada H; Katoh Y
    Rinsho Ketsueki; 1987 Sep; 28(9):1553-60. PubMed ID: 3437517
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute myelogenous leukemia.
    Maiolo AT; Foa P; Cortellaro M; Lambertenghi-Deliliers G; Colantoni A; Cesana B; Castoldi GL; Cazzola M; Giordano M; Riccardi A
    Haematologica; 1987; 72(1):61-5. PubMed ID: 3108098
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of topotecan-based combination therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Beran M; Kantarjian H
    Semin Hematol; 1999 Oct; 36(4 Suppl 8):3-10. PubMed ID: 10622223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Randomized controlled study of very low-dose Ara-C versus low-dose aclarubicin for the treatment of myelodysplastic syndrome].
    Shibuya T; Nagafuji H; Mizuno S; Harada M
    Rinsho Ketsueki; 1996 Sep; 37(9):782-4. PubMed ID: 8914462
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic scoring systems for risk assessment in myelodysplastic syndromes.
    Greenberg PL; Sanz GF; Sanz MA
    Forum (Genova); 1999; 9(1):17-31. PubMed ID: 10101208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of myelodysplastic syndrome (MDS)].
    Kawano F
    Rinsho Ketsueki; 1986 Aug; 27(8):1476-81. PubMed ID: 3795518
    [No Abstract]   [Full Text] [Related]  

  • 16. Myelodysplastic syndromes: what a primary care physician needs to know.
    Khan AM; Komrokji RS; Haddad RY
    Dis Mon; 2010 Aug; 56(8):468-78. PubMed ID: 20800756
    [No Abstract]   [Full Text] [Related]  

  • 17. Differentiating agents + low-dose chemotherapy in the management of old/poor prognosis patients with acute myeloid leukemia or myelodysplastic syndrome.
    Ferrero D; Campa E; Dellacasa C; Campana S; Foli C; Boccadoro M
    Haematologica; 2004 May; 89(5):619-20. PubMed ID: 15136232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome.
    Cortes J; Kantarjian H; Albitar M; Thomas D; Faderl S; Koller C; Garcia-Manero G; Giles F; Andreeff M; O'Brien S; Keating M; Estey E
    Cancer; 2003 Mar; 97(5):1234-41. PubMed ID: 12599230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenesis and treatment of myelodysplastic syndromes and hypoplastic anemia].
    Gavrilov OK; Terent'reva OV
    Klin Med (Mosk); 1990 Aug; 68(8):23-6. PubMed ID: 2084365
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences with low-dos Ara-C in the therapy of hematological neoplasms].
    Jacky E; Frick P
    Ther Umsch; 1988 Feb; 45(2):119-23. PubMed ID: 3358244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.